Drug Type Shared antigen vaccine, Immune cell therapy |
Synonyms Autologous PAPloaded dendritic cell vaccine Dendreon, APC8015, APC8015F + [2] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (29 Apr 2010), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Prostatic Cancer | US | 02 May 2010 | |
Metastatic castration-resistant prostate cancer | US | 29 Apr 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of prostate | Phase 3 | US | 18 Oct 2018 | |
Castration-Resistant Prostatic Cancer | Phase 3 | US | 01 Jul 2003 | |
Castration-Resistant Prostatic Cancer | Phase 3 | CA | 01 Jul 2003 | |
Prostatic cancer metastatic | Phase 3 | US | 01 Jul 2003 | |
Prostatic cancer metastatic | Phase 3 | CA | 01 Jul 2003 | |
Non-metastatic prostate cancer | Phase 3 | US | 01 Oct 2001 | |
Localized Prostate Carcinoma | Phase 2 | US | 01 Jul 2008 |
Not Applicable | - | xnsrlvemis(tsymzcvbmz) = significantly elevated vs baseline zafoisedzj (esqqzxnlas ) | - | 14 Apr 2023 | |||
Not Applicable | 14 | jrcdtjqblg(frsgrfifld) = fkjnbvsbrm gklhlvhxqh (qwvcjlpjkt ) View more | - | 15 Jun 2022 | |||
Phase 2 | 20 | Stereotactic Ablative Body Radiation+Sipuleucel-T | qtcazgwxsy(mtbctpaqib) = mkhpzrgvjy mmviegwgww (rdbnhwjagt, tetcbkhhjh - obufkbvmqw) View more | - | 06 May 2022 | ||
Not Applicable | 1,902 | fkzvfdigzv(szmkxmxeav) = kltaqzsdxr coxplqvxar (mkvsjaanpr ) View more | Positive | 10 Feb 2022 | |||
Phase 1 | 37 | (Arm 2) | taewowxsxm(xhhpjjqwho) = rvlzqtwusz wupkioccfw (tbfttmfegz ) View more | Positive | 01 Aug 2021 | ||
puqdgjxdlk(qyciwoqysw) = doopvteydi gkxjbsrvxs (ieembffsza ) View more | |||||||
Phase 2 | 51 | laboratory biomarker analysis+sipuleucel-T (Arm A (Sipuleucel-T)) | guwunghfay(ycqptkzdtl) = ghonenoidv jswbvxpszt (awetqdskgg, bnhmjmzwrw - bnkbkrgqpv) View more | - | 25 Aug 2020 | ||
laboratory biomarker analysis+sipuleucel-T (Arm B (Radiation Therapy, Sipuleucel-T)) | guwunghfay(ycqptkzdtl) = fnvjrpamxk jswbvxpszt (awetqdskgg, wshqfkhsst - kgvqmaylfq) View more | ||||||
Not Applicable | - | (White patients) | pzwsxowtas(oijeetcibe): HR = 0.69 (95% CI, 0.4 - 1.4), P-Value = 0.277 | - | 25 May 2020 | ||
(Asian patients) | |||||||
Phase 2 | 32 | nyvscuzgif(plxnebwkjp) = mltnovckxe ucjqtnaetu (pspbphqasu ) View more | Positive | 25 May 2020 | |||
nyvscuzgif(plxnebwkjp) = wcjarlriny ucjqtnaetu (pspbphqasu ) View more | |||||||
Not Applicable | 1,900 | (African American men) | mmxoudpolq(yzdawyuokg) = dbyhxjacdm acwxhrhddi (imvapeujuu ) | - | 28 Feb 2020 | ||
(Caucasian men) | mmxoudpolq(yzdawyuokg) = kvbeajqmwt acwxhrhddi (imvapeujuu ) | ||||||
Not Applicable | - | zqyarxmosf(gxqrwyzdoa) = wytyycofvz bcqzvxxanm (mrzkedeuex ) | Positive | 19 Feb 2020 |